Sinocare Inc (300298) - Total Liabilities

Latest as of September 2025: CN¥2.57 Billion CNY ≈ $376.63 Million USD

Based on the latest financial reports, Sinocare Inc (300298) has total liabilities worth CN¥2.57 Billion CNY (≈ $376.63 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sinocare Inc - Total Liabilities Trend (2008–2024)

This chart illustrates how Sinocare Inc's total liabilities have evolved over time, based on quarterly financial data. See 300298 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Sinocare Inc Competitors by Total Liabilities

The table below lists competitors of Sinocare Inc ranked by their total liabilities.

Company Country Total Liabilities
Barloworld Ltd
JSE:BAW
South Africa ZAC26.93 Billion
Compass Minerals International Inc
NYSE:CMP
USA $1.09 Billion
Weibo Corporation
F:2WBA
Germany €3.08 Billion
TF Bank AB
ST:TFBANK
Sweden Skr26.45 Billion
Orezone Gold Corp
TO:ORE
Canada CA$255.87 Million
Xinzhi Motor Co Ltd
SHE:002664
China CN¥7.85 Billion
MRC Global Inc
NYSE:MRC
USA $1.26 Billion
Lapidoth
TA:LAPD
Israel ILA5.47 Billion

Liability Composition Analysis (2008–2024)

This chart breaks down Sinocare Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300298 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.43 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.78 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.41 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sinocare Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sinocare Inc (2008–2024)

The table below shows the annual total liabilities of Sinocare Inc from 2008 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥2.33 Billion
≈ $340.65 Million
-5.22%
2023-12-31 CN¥2.46 Billion
≈ $359.43 Million
+66.68%
2022-12-31 CN¥1.47 Billion
≈ $215.63 Million
+8.26%
2021-12-31 CN¥1.36 Billion
≈ $199.18 Million
+17.86%
2020-12-31 CN¥1.15 Billion
≈ $168.99 Million
+82.57%
2019-12-31 CN¥632.57 Million
≈ $92.56 Million
+67.78%
2018-12-31 CN¥377.01 Million
≈ $55.17 Million
+38.01%
2017-12-31 CN¥273.18 Million
≈ $39.98 Million
+39.61%
2016-12-31 CN¥195.68 Million
≈ $28.63 Million
+108.41%
2015-12-31 CN¥93.89 Million
≈ $13.74 Million
-6.58%
2014-12-31 CN¥100.51 Million
≈ $14.71 Million
-2.14%
2013-12-31 CN¥102.71 Million
≈ $15.03 Million
+1.59%
2012-12-31 CN¥101.10 Million
≈ $14.79 Million
+63.93%
2011-12-31 CN¥61.67 Million
≈ $9.02 Million
+11.95%
2010-12-31 CN¥55.09 Million
≈ $8.06 Million
+85.06%
2009-12-31 CN¥29.77 Million
≈ $4.36 Million
+149.68%
2008-12-31 CN¥11.92 Million
≈ $1.74 Million
--

About Sinocare Inc

SHE:300298 China Medical Devices
Market Cap
$1.17 Billion
CN¥8.01 Billion CNY
Market Cap Rank
#8379 Global
#2049 in China
Share Price
CN¥14.29
Change (1 day)
-1.31%
52-Week Range
CN¥14.29 - CN¥23.46
All Time High
CN¥47.34
About

Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic disease… Read more